calpain inhibitor 2 has been researched along with thapsigargin in 2 studies
| Studies (calpain inhibitor 2) | Trials (calpain inhibitor 2) | Recent Studies (post-2010) (calpain inhibitor 2) | Studies (thapsigargin) | Trials (thapsigargin) | Recent Studies (post-2010) (thapsigargin) |
|---|---|---|---|---|---|
| 68 | 0 | 13 | 5,234 | 3 | 918 |
| Protein | Taxonomy | calpain inhibitor 2 (IC50) | thapsigargin (IC50) |
|---|---|---|---|
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuddon, P; Fleming, A; Floto, RA; Goldsmith, P; Jahreiss, L; O'Kane, CJ; Pask, D; Rubinsztein, DC; Saiki, S; Sarkar, S; Siddiqi, FH; Ttofi, EK; Williams, A | 1 |
| Cribb, AE; Muruganandan, S | 1 |
2 other study(ies) available for calpain inhibitor 2 and thapsigargin
| Article | Year |
|---|---|
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imidazoline Receptors; Minoxidil; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Type C Phospholipases; Verapamil | 2008 |
Calpain-induced endoplasmic reticulum stress and cell death following cytotoxic damage to renal cells.
Topics: Acrylates; Animals; Calpain; Cell Death; Cell Nucleus; Cell Shape; Cell Survival; Chromatin; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Glycoproteins; Heat-Shock Proteins; Immunoblotting; Iodoacetamide; L-Lactate Dehydrogenase; LLC-PK1 Cells; Membrane Proteins; Oligopeptides; Swine; tert-Butylhydroperoxide; Thapsigargin; Time Factors; Tunicamycin; Vitamin K 3 | 2006 |